Aarey Drugs & Pharmaceuticals Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 1,581.8 million compared to INR 1,202.46 million a year ago. Revenue was INR 1,637.21 million compared to INR 1,213.81 million a year ago. Net income was INR 3.63 million compared to net loss of INR 7.55 million a year ago. Basic earnings per share from continuing operations was INR 0.14. Diluted earnings per share from continuing operations was INR 0.14.
For the full year, sales was INR 4,142.53 million compared to INR 4,926.8 million a year ago. Revenue was INR 4,216.86 million compared to INR 4,954.28 million a year ago. Net income was INR 37.77 million compared to INR 65.45 million a year ago. Basic earnings per share from continuing operations was INR 1.49 compared to INR 2.72 a year ago. Diluted earnings per share from continuing operations was INR 1.49 compared to INR 2.72 a year ago.